Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of SEK 3.29 billion. The enterprise value is 3.14 billion.

Market Cap	3.29B
Enterprise Value	3.14B

Important Dates

The next estimated earnings date is Wednesday, August 20, 2025.

Earnings Date	Aug 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	18.25M
Shares Outstanding	n/a
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-0.27%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.61M

Valuation Ratios

The trailing PE ratio is 28.05 and the forward PE ratio is 26.22.

PE Ratio	28.05
Forward PE	26.22
PS Ratio	5.71
PB Ratio	7.39
P/TBV Ratio	8.56
P/FCF Ratio	25.77
P/OCF Ratio	24.65
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.07, with an EV/FCF ratio of 24.59.

EV / Earnings	26.76
EV / Sales	5.42
EV / EBITDA	18.07
EV / EBIT	20.70
EV / FCF	24.59

Financial Position

The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.06.

Current Ratio	3.91
Quick Ratio	2.52
Debt / Equity	0.06
Debt / EBITDA	0.14
Debt / FCF	0.20
Interest Coverage	194.08

Financial Efficiency

Return on equity (ROE) is 27.42% and return on invested capital (ROIC) is 21.22%.

Return on Equity (ROE)	27.42%
Return on Assets (ROA)	17.26%
Return on Invested Capital (ROIC)	21.22%
Return on Capital Employed (ROCE)	31.82%
Revenue Per Employee	3.74M
Profits Per Employee	761,340
Employee Count	154
Asset Turnover	1.05
Inventory Turnover	0.73

Taxes

In the past 12 months, Medistim ASA has paid 35.70 million in taxes.

Income Tax	35.70M
Effective Tax Rate	23.34%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	161.75
200-Day Moving Average	n/a
Relative Strength Index (RSI)	66.01
Average Volume (20 Days)	555

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of SEK 576.25 million and earned 117.25 million in profits. Earnings per share was 6.40.

Revenue	576.25M
Gross Profit	462.45M
Operating Income	150.93M
Pretax Income	152.95M
Net Income	117.25M
EBITDA	164.51M
EBIT	150.93M
Earnings Per Share (EPS)	6.40

Full Income Statement

Balance Sheet

The company has 175.04 million in cash and 24.97 million in debt, giving a net cash position of 150.07 million.

Cash & Cash Equivalents	175.04M
Total Debt	24.97M
Net Cash	150.07M
Net Cash Per Share	n/a
Equity (Book Value)	445.05M
Book Value Per Share	24.36
Working Capital	333.97M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 133.40 million and capital expenditures -5.79 million, giving a free cash flow of 127.61 million.

Operating Cash Flow	133.40M
Capital Expenditures	-5.79M
Free Cash Flow	127.61M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 80.25%, with operating and profit margins of 26.19% and 20.35%.

Gross Margin	80.25%
Operating Margin	26.19%
Pretax Margin	26.54%
Profit Margin	20.35%
EBITDA Margin	28.55%
EBIT Margin	26.19%
FCF Margin	22.15%

Dividends & Yields

Medistim ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	67.07%
Buyback Yield	-0.06%
Shareholder Yield	n/a
Earnings Yield	3.57%
FCF Yield	3.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6